Form 4: Director Stefan Dyckerhoff Sells Astera Labs Shares

Director Stefan Dyckerhoff sold a total of 25,764 shares of Astera Labs common stock across multiple transactions in April 2026.

Summary

• Director Stefan Dyckerhoff executed sales of 25,764 shares of Astera Labs (ALAB) common stock.
• Transactions occurred on April 17, 2026, and April 20, 2026.
• Sales were conducted under a pre-established Rule 10b5-1 trading plan adopted on December 1, 2025.
• Shares were sold at weighted average prices of $175.00 and $175.12 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sales were pre-planned and represent routine portfolio management by an insider.

Positives

• The sales were executed pursuant to a pre-planned Rule 10b5-1 trading plan, which is a standard mechanism for insiders to sell stock without triggering concerns regarding non-public information.

Negatives

• The transaction represents a reduction in the director's direct and indirect beneficial ownership of company stock.

Risks

• Continued insider selling may be perceived negatively by retail investors, potentially impacting short-term stock price volatility.

Future Outlook

No forward-looking guidance or operational outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a routine corporate governance practice for executives and directors to diversify holdings, and it generally does not signal a lack of confidence in the company's long-term prospects.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate insiders to manage equity holdings while maintaining compliance with SEC regulations.
• The scale of the sale relative to the director's total holdings is consistent with typical portfolio rebalancing activities seen in the semiconductor and technology sectors.

Related Party Transactions

• The reporting person holds shares through various trusts and a limited partnership, for which they serve as trustee or general partner.

Stakeholder Impact

• Minimal impact expected on shareholders as the sales were executed under a pre-arranged plan.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Astera Labs, ALAB, Insider Trading, Form 4, Stefan Dyckerhoff, Rule 10b5-1